NCT00332969View on ClinicalTrials.gov

Efficacy of Octreotide Treatment in Patients With Primary Inoperable Thymoma

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

October 31, 2010

Conditions
Thymoma
Interventions
DRUG

Octreotide

Trial Locations (1)

Unknown

Novartis Investigative Site, Regensburg

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY